Kandy

Kandy Boy Launches First Ever App for Customers in All 50 U.S. States to Order & Receive Real THC Products at Home

Retrieved on: 
Friday, November 4, 2022
Home, Hand, Safety, Customer, Cannabis, Kandy, Travel, USPS, THC, Cannabinoid, Online shopping, Amusement arcade, Drug, Delta

Delivery of its Delta THC 9 gummies direct to consumers, via USPS everywhere or delivery trucks in some markets, marks a uniquely convenient and disruptive capability in the cannabis industry.

Key Points: 
  • Kandy Boy Launches First Ever App for Customers in All 50 U.S. States to Order & Receive Real THC Products at Home
    To view an enhanced version of this graphic, please visit:
    Existing online solutions allow customers to order cannabis, but there are significant regulatory barriers that stand in the way of enjoying their purchase.
  • Customers need to visit a dispensary to take delivery, or are required in many jurisdictions to have a medical card.
  • Kandy Boy gummies are made using hemp-derived Delta 9 THC, the same cannabinoid responsible for the psychoactive effects derived from traditional cannabis edibles.
  • "Kandy Boy is unique in bringing optimal convenience, safety, and value to cannabis customers," said Kandy Boy Owner & President Benji Boyce.

Bayer Starts Phase III Clinical Development Program OASIS With Investigational Product, Elinzanetant

Retrieved on: 
Tuesday, August 31, 2021
Research, Women, FDA, Clinical Trials, Other Health, General Health, Pharmaceutical, Consumer, Health, Science, North American Menopause Society, Journal, Phase II, Ageing, Program, Growth, Group, Goal, Longevity, Kandy, Acquisition, Pharmacokinetics, Medical Affairs Bureau, Phase, Science, Menopause, European Menopause and Andropause Society, Research, Hypothalamus, Therapy, Neuron, NAMS, Flash, Trust, Safety, Patient, Sustainable Development Goals, Brain, Woman, United Nations, Attention deficit hyperactivity disorder predominantly inattentive, OASIS, Health, Pharmaceutical industry, Birth control, Menopause, Elinzanetant, Women’s Healthcare at Bayer, Bayer, MENOPAUSE, ELINZANETANT, WOMEN’S HEALTHCARE AT BAYER, BAYER

Bayer, a global leader in womens healthcare, announced today that it started the Phase III clinical development program OASIS, which aims to evaluate the efficacy and safety of the investigational compound, elinzanetant for the treatment of vasomotor symptoms during menopause.

Key Points: 
  • Bayer, a global leader in womens healthcare, announced today that it started the Phase III clinical development program OASIS, which aims to evaluate the efficacy and safety of the investigational compound, elinzanetant for the treatment of vasomotor symptoms during menopause.
  • Based on the positive Phase II data, we are very pleased to now start the Phase III program with the investigational compound elinzanetant to help address vasomotor symptoms women experience during menopause.
  • The OASIS Phase III clinical development program is investigating the efficacy and safety of elinzanetant 120mg once daily in menopausal women with vasomotor symptoms.
  • The design and dosing of the Phase III clinical development program is based on the positive data from two Phase II studies (RELENT-1 and SWITCH-1).

Forbion Portfolio Company, KaNDy Therapeutics, to Be Acquired by Bayer

Retrieved on: 
Tuesday, August 11, 2020
Professional services, Health, Other Health, Finance, Pharmaceutical, Biotechnology, Companies, Industries, Aspirin, Bayer, IG Farben, Leverkusen, Goldman Sachs, Business, Kandy, Forbion, Bayer, KaNDy Therapeutics, NT-814

We are delighted that Bayer has decided to acquire KaNDy and support the ongoing work around the symptoms of menopause.

Key Points: 
  • We are delighted that Bayer has decided to acquire KaNDy and support the ongoing work around the symptoms of menopause.
  • Bayer has been our preferred partner due to its leading position in the area of womens healthcare, said Dr. Mary Kerr, Co-Founder and CEO of KaNDy Therapeutics.
  • Goldman Sachs International is serving as financial advisor to KaNDy Therapeutics Ltd., while Goodwin is serving as legal counsel.
  • Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world.